![](https://hitconsultant.net/wp-content/uploads/2024/04/IMG_3432-1500x786.jpeg)
What you should know:
– Coherent healthrecognized leader in clinical intelligence and prior authorization automation, announced that Humana Inc. (NYSE: HUM) will expand its use of Cohere's prior authorization platform for diagnostic imaging and sleep services.
– In January 2021, Cohere and Humana launched a pilot program in 12 states to improve the prior authorization process for musculoskeletal (MSK) services.
Transformative Prior Authorization Solutions: Cohere's National Impact on Healthcare Access and Provider Satisfaction
The program effectively reduced turnaround times for prior authorization approvals, improved provider satisfaction, and improved care delivery for MS services. This success led to expansion into all 50 states in 2022. As of January 2023, Cohere's solutions were deployed nationally, encompassing cardiovascular and surgical services.
Cohere's prior authorization platform accelerates the approval process for providers and patients. Its unique combination of real-time analytics and evidence-based clinical intelligence reduces refusal rates and facilitates faster access to care for patients.
Each year, Cohere processes 5.5 million prior authorizations, benefiting more than 15 million health plan members and 420,000 healthcare providers nationwide.
“We are excited to have Humana utilize our diagnostic imaging and sleep solutions, strengthening our ongoing strategic partnership,” said Siva Namasivayam, CEO of Cohere Health. “Our solutions leverage the latest evidence-based guidelines from leading medical companies and use cutting-edge technology to align patient services with care pathways through upstream moments of influence, enabling thus faster diagnoses. »